✦ LIBER ✦

Maximally Tolerated Busulfan Systemic Exposure in Combination with Fludarabine as Conditioning before Allogeneic Hematopoietic Cell Transplantation

✍ Scribed by Janelle B. Perkins; Jongphil Kim; Claudio Anasetti; Hugo F. Fernandez; Lia E. Perez; Ernesto Ayala; Mohamed A. Kharfan-Dabaja; Marcie R. Tomblyn; Daniel M. Sullivan; Joseph A. Pidala; Teresa L. Field

Book ID: 116283386
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 304 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.12.584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maximally Tolerated Busulfan Area Under

Maximally Tolerated Busulfan Area Under the Concentration-Time Curve (AUC) in Combination With Fludarabine as Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

✍ J. Perkins; T. Fields; J. Kim; H. Fernandez; L. Perez; E. Ayala; M. Kharfan-Daba 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Targeting once-daily intravenous busulfa

Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation

✍ Jenke, A; Freiberg-Richter, J; Johne, C; Knoth, H; Schleyer, E; Ehninger, G; Bor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Safety Profile of Pharmacokinetically Ta

Safety Profile of Pharmacokinetically Targeted Intravenous Busulfan Combined with Fludarabine (BuFlu) as Conditioning Prior to Allogeneic Peripheral Blood Hematopoietic Cell Transplant

✍ J. Perkins; M. Alsina; E. Ayala; K. Fancher; H. Fernandez; M. Kharfan-Dabaja; L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Fludarabine, Antithymocyte Globulin, and

Fludarabine, Antithymocyte Globulin, and Very Low-Dose Busulfan for Reduced-Intensity Conditioning before Allogeneic Stem Cell Transplantation in Patients with Lymphoid Malignancies

✍ Florent Malard; Xavier Cahu; Aline Clavert; Eolia Brissot; Patrice Chevallier; T 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 232 KB

Low treatment related mortality and impr

Low treatment related mortality and improved survival in allogeneic peripheral blood stem cell transplant: Targeted intravenous Busulfan combined with Fludarabine (tBuFlu) as conditioning regimen

✍ T.L. Field; J. Perkins; M. Alsina; E. Ayala; K. Fancher; W. Janssen; L. Perez; D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Comparison between two fludarabine-based

Comparison between two fludarabine-based reduced-intensity conditioning regimens before allogeneic hematopoietic stem-cell transplantation: fludarabine/melphalan is associated with higher incidence of acute graft-versus-host disease and non-relapse mortality and lower incidence of relapse than fludarabine/busulfan

✍ Shimoni, A; Hardan, I; Shem-Tov, N; Rand, A; Herscovici, C; Yerushalmi, R; Nagle 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 162 KB